533885-37-9 Usage
Uses
Used in Pharmaceutical Industry:
2-(pyridin-4-yl)thiazole-4-carbaldehyde is used as a building block for the synthesis of pharmaceuticals due to its biological activities, including antimicrobial, antiviral, and anticancer properties. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 2-(pyridin-4-yl)thiazole-4-carbaldehyde is used in the development of new agrochemicals, leveraging its antimicrobial properties to create effective solutions for crop protection and pest control.
Used as a Reagent in Organic Synthesis:
2-(pyridin-4-yl)thiazole-4-carbaldehyde is utilized as a reagent in organic synthesis, contributing to the formation of various heterocyclic compounds that have a wide range of applications in different fields, including medicine, materials science, and chemical research.
Used in the Preparation of Heterocyclic Compounds:
2-(pyridin-4-yl)thiazole-4-carbaldehyde is also employed in the preparation of heterocyclic compounds, which are important in various chemical and pharmaceutical applications due to their diverse chemical properties and potential uses in drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 533885-37-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,3,3,8,8 and 5 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 533885-37:
(8*5)+(7*3)+(6*3)+(5*8)+(4*8)+(3*5)+(2*3)+(1*7)=179
179 % 10 = 9
So 533885-37-9 is a valid CAS Registry Number.
533885-37-9Relevant academic research and scientific papers
HIV PROTEASE INHIBITING COMPOUNDS
-
Page/Page column 156-157, (2010/02/12)
A compound of the formula (I) is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
HIV PROTEASE INHIBITING COMPOUNDS
-
Page/Page column 104, (2010/02/12)
A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
